GlaxoSmithKline Plc said an injection of its cabotegravir drug given every two months, in combination with Johnson & Johnson's rilpivirine, was recommended for approval to treat HIV infections by a ...

Roche has received approval from the United States Food and Drug Administration for its Cobas qualitative testing systems to confirm HIV diagnosis, the Swiss pharmaceuticals company said on Tuesday.

Human immunodeficiency viruses (HIV) are insidious. They can evade the immune defense and antiviral drugs by becoming "latent ...

Called “bluetoothing,” the gruesome movement is fueling a wave of new HIV infections in hotspots around the globe, including ...

SINCE the 1980s, researchers have worked tirelessly to develop effective treatments that can suppress the HIV virus to undetectable levels. As a result, by taking a single daily dose of an ...

The practice, in which users inject the blood of already intoxicated individuals, has fueled one of the fastest-growing H.I.V ...

Supporting global efforts to end AIDS by 2032 through the introduction of lenacapavir as a game-changing HIV prevention tool ...

A federal grant for HIV research is part of $15.7 million the National Institutes for Health awarded to the Wertheim UF Scripps Institute in Jupiter.

Our projections show the substantial detrimental impacts that cuts to PEPFAR funding could have. Mitigation measures, including funding through alternative international donors or domestic government ...

The Ghana AIDS Commission has announced plans to introduce an HIV preventive vaccine by 2026 as part of efforts to reduce new infections and strengthen the country’s fight against the virus.

SCOTLAND is making “good progress” towards the goal of eliminating transmission of the HIV virus by 2030, a new report has said.

Scotland is making “good progress” towards the goal of eliminating transmission of the HIV virus by 2030, a new report has ...